FLT3 inhibitors as MRD-guided salvage treatment for molecular failure in FLT3 mutated AML

Jad Othman, Nicola Potter, Katya Mokretar, David Taussig, Anjum Khan, Pramila Krishnamurthy, Anne-Louise Latif, Paul Cahalin, James Aries, Mariam Amer, Edward Belsham, Eibhlin Conneally, Charles Craddock, Dominic Culligan, Mike Dennis, Caroline Duncan, Sylvie D Freeman, Caroline Furness, Amanda Gilkes, Paraskevi GkrekaKatherine Hodgson, Wendy Ingram, Manish Jain, Andrew King, Steven Knapper, Panagiotis Kottaridis, Mary Frances McMullin, Unmesh Mohite, Loretta Ngu, Jenny O'Nions, Katharine Patrick, Tom Rider, Wing Roberts, Marianne Tang Severinsen, Neill Storrar, Tom Taylor, Nigel H Russell, Richard Dillon*

*Corresponding author for this work

    Research output: Contribution to journal › Article › peer-review

    24 Downloads (Pure)

    Fingerprint

    Dive into the research topics of 'FLT3 inhibitors as MRD-guided salvage treatment for molecular failure in FLT3 mutated AML'. Together they form a unique fingerprint.

    Medicine & Life Sciences